Atomera(US:ATOM)2021-05-06 16:00Revenue - Revenue for Q1 2021 was approximately $400,000, a significant increase from $62,000 in Q1 2020, primarily due to a manufacturing license payment under a joint development agreement (JDA) [69]. - The company anticipates increased revenue from licensing agreements and royalties from products incorporating MST technology in the future [67]. - The company has generated revenue through a JDA, licensing agreements with two integrated device manufacturers (IDMs), and engineering services [64]. Operating Expenses - Operating expenses for Q1 2021 totaled approximately $4.0 million, compared to $3.7 million in Q1 2020, reflecting an increase of about 8% in research and development expenses [69]. - Research and development expenses for Q1 2021 were approximately $2.2 million, up from $2.1 million in Q1 2020, driven by additional headcount [72]. - General and administrative expenses for Q1 2021 were approximately $1.5 million, an increase of about 5% from $1.4 million in Q1 2020, mainly due to higher payroll-related expenses [73]. - Selling and marketing expenses for Q1 2021 were approximately $266,000, a decrease of about 18% from $225,000 in Q1 2020, attributed to lower travel expenses [74]. Cash Flow and Financial Position - Net cash used in operating activities for Q1 2021 was approximately $3.9 million, primarily due to a net loss of approximately $3.6 million [76]. - As of March 31, 2021, the company had cash and cash equivalents of approximately $36.7 million and working capital of approximately $36.4 million [78]. - Future capital requirements will depend on the successful commercialization of MST technology and may necessitate raising additional capital if revenue generation does not meet cash needs [79].